Member of the Association of American Physicians
His primary areas of investigation include Internal medicine, Endocrinology, Insulin, Glucagon-like peptide-1 and Glucagon. His Type 2 diabetes research extends to Internal medicine, which is thematically connected. His study involves Postprandial, Obesity, Weight loss, Glucose tolerance test and Insulin resistance, a branch of Endocrinology.
His studies in Postprandial integrate themes in fields like Ingestion, Ghrelin and Recurrent hypoglycemia. The Insulin study combines topics in areas such as Diabetes mellitus and Bolus. His study in Glucagon-like peptide-1 is interdisciplinary in nature, drawing from both Incretin, Small intestine, Gastrointestinal hormone, Enteroendocrine cell and Ileum.
David A. D'Alessio mostly deals with Internal medicine, Endocrinology, Insulin, Diabetes mellitus and Glucagon-like peptide-1. His studies link Type 2 diabetes with Internal medicine. Endocrinology is represented through his Glucagon, Incretin, Postprandial, Insulin resistance and Hormone research.
In his study, Saline is strongly linked to Ghrelin, which falls under the umbrella field of Insulin. His Diabetes mellitus research incorporates elements of Body mass index, Gastric emptying and Surgery. His work carried out in the field of Glucagon-like peptide-1 brings together such families of science as Gastrointestinal hormone, Receptor and Insulin secretion.
Internal medicine, Endocrinology, Diabetes mellitus, Incretin and Receptor are his primary areas of study. Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. His is involved in several facets of Endocrinology study, as is seen by his studies on Glucagon, Islet, Carbohydrate metabolism, Postprandial and Insulin.
His studies deal with areas such as Meal and Gastric bypass surgery as well as Postprandial. His Diabetes mellitus research includes elements of Obesity, Disease and Pharmacology. The various areas that he examines in his Receptor study include Glucagon-like peptide-1, Proglucagon, Messenger RNA and Cell biology.
David A. D'Alessio spends much of his time researching Diabetes mellitus, Internal medicine, Receptor, Endocrinology and Insulin. His Diabetes mellitus study combines topics from a wide range of disciplines, such as Agonist, Sleeve gastrectomy and Obesity. In his papers, David A. D'Alessio integrates diverse fields, such as Internal medicine and Placebo.
His Receptor research is multidisciplinary, incorporating perspectives in Incretin, Glucagon-like peptide-1, Pharmacology and Cell biology. His Glucagon-like peptide-1 research is multidisciplinary, incorporating elements of Genetically modified mouse and Insulin resistance. His work is connected to Hormone, Carbohydrate metabolism, Postprandial and Beta cell, as a part of Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies;David A. D’Alessio;Judith Fradkin;Walter N. Kernan.
Diabetes Care (2018)
A Randomized Trial Comparing a Very Low Carbohydrate Diet and a Calorie-Restricted Low Fat Diet on Body Weight and Cardiovascular Risk Factors in Healthy Women
Bonnie J. Brehm;Randy J. Seeley;Stephen R. Daniels;David A. D’Alessio.
The Journal of Clinical Endocrinology and Metabolism (2003)
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies;Melanie J. Davies;David A. D’Alessio;Judith Fradkin;Walter N. Kernan.
Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.
Karen L Teff;Sharon S Elliott;Matthias Tschöp;Timothy J Kieffer.
The Journal of Clinical Endocrinology and Metabolism (2004)
Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1
Sung Hee Um;David D'Alessio;David D'Alessio;George Thomas.
Cell Metabolism (2006)
A Controlled High-Fat Diet Induces an Obese Syndrome in Rats
Stephen C. Woods;Randy J. Seeley;Paul A. Rushing;David D’Alessio.
Journal of Nutrition (2003)
Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis.
Mercedes Falciglia;Ron W. Freyberg;Peter L. Almenoff;David A. D’Alessio.
Critical Care Medicine (2009)
Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells
Steven E Kahn;David A D'Alessio;Michael W Schwartz;Wilfred Y Fujimoto.
Central Control of Body Weight and Appetite
Stephen C. Woods;David A. D'Alessio.
The Journal of Clinical Endocrinology and Metabolism (2008)
Glucagon-like peptide 1 (GLP-1)
T.D. Müller;B. Finan;S.R. Bloom;D. D'Alessio.
Molecular metabolism (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: